LexDanaLexDanabeta
Inventor

Paul F. Jackson

Inventor
Bel Air, MD, US

Overview

58→
Patents
1996–2014
Patent span
Chemistry
Primary field (CPC C)

Patents· 58 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Fprimary
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium26%
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds19%
C07CAcyclic or carbocyclic compounds4%
C12NMicroorganisms or enzymes1%
C07KPeptides1%
C12YEnzymes1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology1%
PatentTitleYear
8,883,473'Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases'20148,798,939'Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinases'20148,753,857'Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor'20148,017,614'Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists'20117,803,793'Heterocyclic derived metalloprotease inhibitors'20106,903,109'Arylindenopyridines and related therapeutic and prophylactic methods'20056,852,750'Benzenedicarboxylic acid derivatives'20056,635,642'PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same'20036,514,983'Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage'20036,479,471'NAALADase inhibitors'20026,458,775'NAALADase inhibitors useful as pharmaceutical compounds and compositions'20026,452,044'Benzenedicarboxylic acid derivatives'20026,426,415'Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity'20026,413,948'Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors'20026,384,022'Prodrugs of NAALAdase inhibitors'20026,380,211'Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity'20026,372,726'Methods of cancer treatment using NAALADase inhibitors'20026,348,464'Pyrrolecarbonylimino derivatives as naaladase inhibitors'20026,346,536'Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same'20026,313,159'Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors'20016,306,889'Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage'20016,288,046'Phosphonic acid derivatives'20016,271,245'Hydroxamic acid derivatives'20016,265,609'Thio-substituted pentanedioic acid derivatives'20016,214,826'Pyridazino quinoline compounds'20016,197,785'Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity'20016,121,252'Phosphinic acid derivatives'20006,121,278'Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity'20006,071,965'Phosphinic alkanoic acid derivatives'20006,054,444'Phosphonic acid derivatives'20006,046,180'NAALADase inhibitors'20006,028,216'Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives'20006,025,345'Inhibitors of NAALADase enzyme activity'20006,025,344'Certain dioic acid derivatives useful as NAALADase inhibitors'20006,017,903'Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors'20006,011,021'Methods of cancer treatment using naaladase inhibitors'20006,004,946'Treatment of global and focal ischemia using naaladase inhibitors'19995,985,855'Treatment of global and focal ischemia using NAALADase inhibitors'19995,977,090'Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors'19995,968,915'Naaladase inhibitors'19995,962,521'Hydroxamic acid derivatives'19995,925,666'Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives'19995,902,817'Certain sulfoxide and sulfone derivatives'19995,880,112'Naaladase inhibitors'19995,863,536'Phosphoramidate derivatives'19995,824,662'Treatment of global and focal ischemia using naaladase inhibitors'19985,804,602'Methods of cancer treatment using naaladase inhibitors'19985,801,168'Substituted nitrogen heterocycles'19985,795,877'Inhibitors of NAALADase enzyme activity'19985,747,523'Substituted ethyl .alpha.,.alpha.-diarylmethyl ether derivatives'19985,712,272'Therapeutic compositions'19985,672,592'Certain phosphonomethyl-pentanedioic acid derivatives thereof'19975,656,626'Substituted nitrogen heterocycles'19975,654,295'Therapeutic compositions'19975,652,239'Pyridazinedione derivatives useful in treatment of neurological disorders'19975,650,521'Pyrrolidine derivatives'19975,502,048'Substituted nitrogen heterocycles'19965,492,905'1-bolizazepin-2,5-diones'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996–2001Patents assigned to ZENECA LTD (7)· patent assignee history
1996–1998Based in Chadds Ford, PA, US· patent location history
1997–2005Patents assigned to GUILFORD PHARM INC (44)· patent assignee history
1997–2003Based in Bel Air, MD, US· patent location history
2002–2005Based in White House Station, NJ, US· patent location history
2005–2010Based in Whitehouse Station, NJ, US· patent location history
2010–2014Patents assigned to JANSSEN PHARMACEUTICA NV (5)· patent assignee history
2014Patents assigned to ALEXANDER RICHARD SCOTT (3)· patent assignee history
2014Patents assigned to BARBAY JOSEPH KENT (3)· patent assignee history
2014Based in Furlong, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GUILFORD PHARM INC441997–2005
ZENECA LTD71996–2001
JANSSEN PHARMACEUTICA NV52010–2014
ALEXANDER RICHARD SCOTT32014
BARBAY JOSEPH KENT32014
Locations
LocationPatentsSpan
Bel Air, Maryland, US431997–2003
Chadds Ford, Pennsylvania, US71996–1998
Furlong, Pennsylvania, US32014
Whitehouse Station, New Jersey, US22005–2010
White House Station, New Jersey, US22002–2005